EGM
TEVA icon

Engineers Gate Manager’s Teva Pharmaceuticals TEVA Stock Holding History

Engineers Gate Manager’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,841
Closed -$1.14M – 2613
2026
Q1 		$1.14M Buy
+37,841
New +$1.22M 0.01% 983
2025
Q3 		– Sell
-35,340
Closed -$592K – 2525
2025
Q2 		$592K Sell
35,340
-70,355
-67% -$1.14M 0.01% 1404
2025
Q1 		$1.62M Buy
+105,695
New +$1.89M 0.03% 795
2024
Q4 		– Sell
-50,157
Closed -$904K – 2569
2024
Q3 		$904K Buy
50,157
+26,015
+108% +$455K 0.02% 1058
2024
Q2 		$392K Sell
24,142
-35,627
-60% -$549K 0.01% 1330
2024
Q1 		$843K Sell
59,769
-29,693
-33% -$374K 0.02% 925
2023
Q4 		$934K Buy
89,462
+63,140
+240% +$590K 0.03% 833
2023
Q3 		$268K Sell
26,322
-53,034
-67% -$494K 0.01% 1369
2023
Q2 		$598K Buy
79,356
+22,457
+39% +$182K 0.02% 950
2023
Q1 		$504K Sell
56,899
-17,126
-23% -$169K 0.02% 971
2022
Q4 		$675K Buy
74,025
+59,220
+400% +$517K 0.04% 723
2022
Q3 		$119K Sell
14,805
-17,295
-54% -$153K 0.01% 1422
2022
Q2 		$241K Buy
+32,100
New +$280K 0.01% 1549
2022
Q1 		– Sell
-67,000
Closed -$537K – 2303
2021
Q4 		$537K Buy
67,000
+56,600
+544% +$511K 0.02% 1000
2021
Q3 		$101K Buy
+10,400
New +$97.4K 0.01% 1531
2021
Q2 		– Sell
-27,960
Closed -$323K – 2009
2021
Q1 		$323K Buy
27,960
+10,960
+64% +$126K 0.02% 1275
2020
Q4 		$164K Sell
17,000
-17,900
-51% -$171K 0.01% 1521
2020
Q3 		$314K Sell
34,900
-39,073
-53% -$413K 0.01% 1223
2020
Q2 		$912K Buy
73,973
+30,236
+69% +$342K 0.05% 641
2020
Q1 		$393K Sell
43,737
-14,263
-25% -$146K 0.03% 908
2019
Q4 		$568K Buy
58,000
+42,900
+284% +$383K 0.03% 930
2019
Q3 		$104K Buy
15,100
+3,500
+30% +$26.8K 0.01% 1306
2019
Q2 		$107K Buy
+11,600
New +$140K 0.01% 1054

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Engineers Gate Manager's TEVA Position: Q2 2026 in Review

Engineers Gate Manager sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 37,841 shares — an estimated $1.14M sold.

Engineers Gate Manager first reported a position in TEVA in Q2 2019 and held it in 23 quarters. The position peaked at $1.62M in Q1 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Engineers Gate Manager reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 37,841 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.14M.
  • Engineers Gate Manager first reported a position in Teva Pharmaceuticals in Q2 2019 and held it in 23 quarters.
  • Engineers Gate Manager's Teva Pharmaceuticals position peaked at $1.62M in Q1 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.